Загрузка...
Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1
BACKGROUND: The histone demethylase LSD1 is a key mediator driving tumorigenesis, which holds potential as a promising therapeutic target. However, treatment with LSD1 inhibitors alone failed to result in complete cancer regression. METHODS: The synergistic effects of TCP (a LSD1 inhibitor) and GSK-...
Сохранить в:
| Опубликовано в: : | Br J Cancer |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028736/ https://ncbi.nlm.nih.gov/pubmed/31848446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0680-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|